Thoracolumbar fascia mobilization versus ultrasound-guided 5% dextrose injection for chronic low back pain
Official title: Comparison of the Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided Thoracolumbar Interfascial 5% Dextrose Injection in Patients With Chronic Low Back Pain
Run by Ankara City Hospital Bilkent · NCT07241559 · Data updated 2026-11-12
This study will try two treatments—hands-on thoracolumbar fascia mobilization and ultrasound-guided 5% dextrose injections—to see if they reduce pain and improve movement and function in adults with chronic low back pain who have not adequately improved with medical treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Locations | 1 site (Ankara, Altındağ) |
| Status | Recruiting |
| Started | November 1, 2025 |
| Main results expected | April 1, 2026 |
| Study ends | July 1, 2026 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT07241559 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with nonspecific low back pain lasting more than three months who have not had an adequate response to medical treatment and who meet the trial's exclusion criteria are ideal candidates.
✕Probably not a fit
Patients with prior spinal surgery, radiculopathy or disc pathology causing nerve root symptoms, spinal stenosis/spondylolysis/spondylolisthesis, BMI over 30, pregnancy, coagulation disorders, recent physical therapy or lumbar injections, local infection, or active inflammatory or malignant disease are unlikely to be eligible or to benefit from these interventions in this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional trial compares hands-on thoracolumbar fascia mobilization with ultrasound-guided interfascial injections of 5% dextrose in adults who have nonspecific chronic low back pain. Participants are assigned to one of three groups, with the mobilization group receiving standardized myofascial release twice weekly for three weeks and the injection group treated under ultrasound guidance to the thoracolumbar interfascial space. Primary outcomes include pain intensity, lumbar range of motion, and functional disability, while secondary outcomes include quality of life, proprioception, and thoracolumbar fascia thickness and echogenicity. Eligible participants are adults aged 18–65 without prior spinal surgery, radiculopathy, major inflammatory or malignant disease, recent manual therapy or injections, or other exclusionary conditions.
Why it matters
Potential benefit: If successful, these approaches could reduce chronic low back pain and improve mobility, daily function, and quality of life for affected patients.
How similar studies have gone: Smaller randomized and observational studies of dextrose prolotherapy and of myofascial release have shown mixed but sometimes promising results for chronic low back pain, and direct head-to-head comparisons remain relatively limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female patients aged 18 to 65 years 2. Presence of low back pain lasting longer than 3 months 3. No adequate response to medical treatment 4. Voluntary participation in the study Exclusion Criteria: 1. Age below 18 or above 65 years 2. Body mass index (BMI) greater than 30 kg/m² 3. Pregnancy or breastfeeding 4. Presence of coagulation disorders 5. History of spinal surgery 6. Presence of inflammatory or malignant diseases 7. Local infection at the spine or injection site 8. Presence of lumbar disc pathology causing radiculopathy 9. Presence of spinal stenosis, spondylolysis, or spondylolisthesis 10. Participation in physical therapy or any manual therapy within the past 6 months 11. Receiving lumbar injections within the past 6 months 12. History of allergy to injection materials 13. Refusal to participate in the study
Where it's running
-
Ankara Training and Research Hospital
Ankara, Altındağ, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Büşra ALÇIN, Medical Doctor — Ankara Training and Research Hospital
- Study coordinator: Barış NACIR, Professor Doctor
- Email: drbarisnacir@gmail.com
- Phone: +905327278724
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Palmitoylethanolamide for Central Sensitisation and Neuroinflammation in Chronic Low Back Pain
A treatment with palmitoylethanolamide is being tried to see if it helps people with chronic low back pain who have nerve-related pain and disc problems.
-
Multichannel neuromuscular stimulation plus core exercise for chronic low back pain
This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.